Gene · 10763
Papers2,854
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,854
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth. | Einstein (Sao Paulo) | 2023 | 37970951 | PubTator, text mining | PubMed |
| Characterization of neural stem cells derived from human stem cells from the apical papilla undergoing three-dimensional neurosphere induction. | J Appl Oral Sci | 2023 | 37970885 | PubTator, text mining | PubMed |
| Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells. | Cancers (Basel) | 2023 | 37958423 | PubTator, text mining | PubMed |
| β-adrenergic signaling triggers enteric glial reactivity and acute enteric gliosis during surgery. | J Neuroinflammation | 2023 | 37941007 | PubTator, text mining | PubMed |
| The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells. | Sci Adv | 2023 | 37922359 | PubTator, text mining | PubMed |
| Pluripotent stem cell-derived neural progenitor cells can be used to model effects of IL-6 on human neurodevelopment. | Dis Model Mech | 2023 | 37921007 | PubTator, text mining | PubMed |
| Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease. | Fluids Barriers CNS | 2023 | 37907966 | PubTator, text mining | PubMed |
| Remodeling the cellular stress response for enhanced genetic code expansion in mammalian cells. | Nat Commun | 2023 | 37903771 | PubTator, text mining | PubMed |
| Survival and Enrichment Analysis of Epithelial-Mesenchymal Transition Genes in Bladder Urothelial Carcinoma. | Genes (Basel) | 2023 | 37895248 | PubTator, text mining | PubMed |
| Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression. | BMC Urol | 2023 | 37845668 | PubTator, text mining | PubMed |
| Morphogenesis and development of human telencephalic organoids in the absence and presence of exogenous extracellular matrix. | EMBO J | 2023 | 37842725 | PubTator, text mining | PubMed |
| Low Levels of Amyloid Precursor Protein (APP) Promote Neurogenesis and Decrease Gliogenesis in Human Neural Stem Cells. | Int J Mol Sci | 2023 | 37834082 | PubTator, text mining | PubMed |
| Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. | Nat Commun | 2023 | 37805522 | PubTator, text mining | PubMed |
| Rare intercellular material transfer as a confound to interpreting inner retinal neuronal transplantation following internal limiting membrane disruption. | Stem Cell Reports | 2023 | 37802075 | PubTator, text mining | PubMed |
| Mapping oto-pharyngeal development in a human inner ear organoid model. | Development | 2023 | 37796037 | PubTator, text mining | PubMed |
| Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas. | Clin Transl Med | 2023 | 37784249 | PubTator, text mining | PubMed |
| The matrix microenvironment influences but does not dominate tissue-specific stem cell lineage differentiation. | Mater Today Bio | 2023 | 37766896 | PubTator, text mining | PubMed |
| The Antitumor Activity of Piplartine: A Review. | Pharmaceuticals (Basel) | 2023 | 37765054 | PubTator, text mining | PubMed |
| Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers. | Int J Mol Sci | 2023 | 37762559 | PubTator, text mining | PubMed |
| Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons. | Int J Mol Sci | 2023 | 37762529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10763/papers?page=7